Common adverse effects of GLP-1 medications include gastrointestinal symptoms such as nausea, vomiting, diarrhoea, and constipation, particularly during dose escalation
If adverse drug reactions occur, contact your healthcare professional, pharmacist, or directly to the information database on adverse drug reactions (actions), including reports of drug ineffectiveness RSE on REM National Center for Expertise of Medicines and Medical Devices of the Committee for Medical and Pharmaceutical Control of the Ministry of Health of the Republic of Kazakhstan additional information Composition of the medicinal product One bottle contains: active substance: reduced glutathione sodium salt 0.646 g, corresponds to 600 mg reduced glutathione one ampoule with solvent contains: water for injection Release form and packaging 0.646 g of the drug is placed in a transparent glass bottle, sealed with a rubber stopper and sealed with an aluminum cap
Purpose The purpose of L-Carnitine is to give you the extra boost for your fitness routine
While these findings are concerning, they are preliminary and require further investigation
The worst episodes typically occur during dose escalation phases and resolve 2 to 3 weeks after reaching a stable dose
Researchers looked at 37.1 million adults with type 2 diabetes across this dataset and found a modest increase in the risk of NAION among individuals with [type 2 diabetes] associated with semaglutide use. A study published in June 2025 also connected GLP-1 RAs to neovascular age-related macular degeneration (nAMD)